Serum tissue factor as a biomarker for renal clear cell carcinoma

Silva, Daniel D'Oliveira; Noronha, Jorge A. P; Costa, Bartira E. Pinheiro da; Zandona, Pedro Caetano Edler; Carvalhal, Gustavo F.
Int. braz. j. urol ; 44(1): 38-44, Jan.-Feb. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-892961

Documentos relacionados

  1. Serum tissue factor as a biomarker for renal clear cell carcinoma.
  2. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
  3. ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy.
  4. Preoperative serum total cholesterol is a predictor of prognosis in patients with renal cell carcinoma: a meta- analysis of observational studies.
  5. MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma.
  6. Bioinformatic Analysis and Clinical Case Studies Identify CD276 as a Promising Diagnostic Biomarker for Clear Cell Renal Cell Carcinoma.
  7. The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis.
  8. [Aberrant expression of arrestin-1 and recoverin in kidney tumors].
  9. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
  10. Characterization of extrachromosomal circular DNAs in plasma of patients with clear cell renal cell carcinoma.